Founded Year

1863

Stage

PIPE - II | IPO

Market Cap

27.54B

Stock Price

28.03

Revenue

$0000 

About Bayer

Bayer operates as a company focused on healthcare and nutrition. The company offers products and services that cater to human needs related to health and nutrition, addressing the challenges posed by a growing global population. Bayer's efforts aim to improve patient care and enhance nutrition. It was founded in 1863 and is based in Leverkusen, Germany.

Headquarters Location

Kaiser-Wilhelm-Allee 1

Leverkusen, 51373,

Germany

+49 (0)214 30-1

Loading...

Loading...

Expert Collections containing Bayer

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Bayer is included in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Bayer Patents

Bayer has filed 5227 patents.

The 3 most popular patent topics include:

  • herbicides
  • transcription factors
  • acetylcholinesterase inhibitors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/24/2022

4/8/2025

3D imaging, Stereoscopy, Cosmetics, Robotic manipulators, Cosmetic industry

Grant

Application Date

6/24/2022

Grant Date

4/8/2025

Title

Related Topics

3D imaging, Stereoscopy, Cosmetics, Robotic manipulators, Cosmetic industry

Status

Grant

Latest Bayer News

Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Projected to Reach $19.28 Billion with 17.3% CAGR by 2029

Sep 11, 2025

Get 30% Off All Global Market Reports With Code ONLINE30 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, September 11, 2025 / EINPresswire.com / -- "Get 30% Off All Global Market Reports With Code ONLINE30 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors What Is The Expected Cagr For The Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Through 2025? The market size for the reading, writing, and editing of deoxyribonucleic acid (DNA) has seen significant growth in recent times. Currently valued at $8.65 billion in 2024, this market is projected to hit $10.18 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 17.7%. The historic growth of this market is due to factors such as the rising incidence of genetic disorders, increased demand for personalized medicine, expansion of academic and industrial research in genomics, growing utilization of next-generation sequencing, and the rise in government and private funding for sequencing infrastructure. Expectations are set high for dramatic expansion in the market size for DNA reading, writing, and editing over the next few years. By 2029, it is projected to reach an impressive valuation of $19.28 billion, exhibiting a compound annual growth rate (CAGR) of 17.3%. This anticipated expansion in the forecast period is attributable to several key factors, including escalating demand for precision medical treatments, increasing investment in DNA-related data storage, wider acceptance of synthetic biology, proliferation of DNA sequencing services, and heightened awareness for early detection of diseases. The key trends that are predicted to shape the this period of growth include strides forward in genome editing technology, ongoing innovation in DNA synthesis processes, advancement in portable sequencing apparatus, significant progress in research and development, and enhancements in bioinformatics tools. Download a free sample of the deoxyribonucleic acid (dna) read, write and edit market report: https://www.thebusinessresearchcompany.com/sample.aspx?id=27274&type=smp What Are The Key Factors Driving Growth In The Deoxyribonucleic Acid (DNA) Read, Write And Edit Market? The escalating occurrence of genetic disorders is projected to stimulate the advancement of the deoxyribonucleic acid (DNA) read, write, and edit market in the future. These medical conditions, caused by abnormalities in an individual's deoxyribonucleic acid either through inheritance from one or both parents or evolving from fresh mutations, are escalating due to the increased age of parents. Older parents bear a higher risk of transmitting genetic mutations to their offspring. Reading, writing, and editing deoxyribonucleic acid (DNA) can ameliorate these genetic disorders by allowing for precise identification, rectification, and alteration of genes causing diseases. These techniques not only enhance healthcare outcomes but also facilitate targeted therapies, lessen the risk of inherited conditions, and promote personalized medicine for affected patients. For instance, data from the UK-based government department, National Health Service, in May 2024 stated that about 17,000 people were living with the inherited genetic blood disorder called sickle cell disease, with an estimated 250 new cases diagnosed every year. Consequently, the escalating occurrence of genetic disorders is fueling the advancement of the deoxyribonucleic acid (DNA) read, write, and edit market. What Are The Top Players Operating In The Deoxyribonucleic Acid (DNA) Read, Write And Edit Market? Major players in the Deoxyribonucleic Acid (DNA) Read, Write And Edit Global Market Report 2025 include: • Roche Holding AG • Bayer AG • Thermo Fisher Scientific Inc. • Danaher Corporation • Agilent Technologies Inc. • MGI Tech • Bio-Rad Laboratories Inc. • BGI Group • Ginkgo Bioworks • Oxford Nanopore Technologies What Are The Key Trends Shaping The Deoxyribonucleic Acid (DNA) Read, Write And Edit Industry Leading businesses in the deoxyribonucleic acid (DNA) reading, writing, and editing market are turning their attention to developing progressive products such as top-notch, regulatory-approved synthetic DNA, with the aim of quickening research, ensuring safety, and assisting in the commercial launch of advanced treatments. This kind of synthetic DNA is artificially created DNA which is accurate, free from contaminants, and developed in line with safety and legal regulations, making it ideal for research, diagnostics, and therapeutic uses. To illustrate, GenScript Inc., a biotechnology company based in the US, introduced GenExact (GMP single-stranded DNA) and GenWand (GMP closed-end linear double-stranded DNA) services in May 2022. These services facilitate swift progression from research and development to investigational new drug (IND) filing and clinical trials, by supplying high-quality HDR templates that are non-viral, promoting safer and more efficient CRISPR non-viral gene insertion for advanced cell and gene therapies. This DNA, produced in dedicated cGMP facilities and supported by full documentation and regulatory backing, is robustly examined to ensure it upholds standards for identity, purity, potency, and safety, thus presenting a dependable and expandable source of genetic material suitable for therapeutic applications. Comprehensive Segment-Wise Insights Into The Deoxyribonucleic Acid (DNA) Read, Write And Edit Market The deoxyribonucleic acid (DNA) read, write and edit market covered in this report is segmented 1) By Types: Kits And Reagents, Cell Line Engineering, Animal Models, Services 2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nucleases (Talen), Zinc Finger Nucleases, Other Technologies 3) By Delivery Mode: Viral Vectors, Non-Viral Vectors, Electroporation, Microinjection 4) By Application: Gene Therapy, Diagnostics, Biotechnology, Agricultural, Synthetic Biology 5) By End Users: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Clinical Research Organizations Subsegments: 1) By Kits And Reagents: Deoxyribonucleic Acid Kits (DNA Kits), Ribonucleic Acid Kits (RNA Kits), Protein Assay Kits (PA Kits), Gene Editing Reagents (GER), Polymerase Chain Reaction Reagents (PCR Reagents) 2) By Cell Line Engineering: Stable Cell Lines (SCL), Transient Cell Lines (TCL), Hybridoma Cell Lines (HCL), Reporter Cell Lines (RCL), Primary Cell Lines (PCL) 3) By Animal Models: Transgenic Animals (TA), Knockout Animals (KA), Humanized Animals (HA), Xenograft Models (XM), Inbred Strains (IS) 4) By Services: Custom Gene Editing (CGE), Cell Line Development (CLD), Animal Model Development (AMD), Analytical Testing Services (ATS), Consulting Services (CS) View the full deoxyribonucleic acid (dna) read, write and edit market report: https://www.thebusinessresearchcompany.com/report/deoxyribonucleic-acid-dna-read-write-and-edit-global-market-report Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Market - Regional Insights In 2024, North America stood as the leading region in the global market for DNA read, write, and edit. It is projected that Asia-Pacific will experience the most rapid growth in the mentioned forecast period. The report encompasses several regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Browse Through More Reports Similar to the Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Market 2025, By The Business Research Company Architectural Lighting Global Market Report 2025 https://www.thebusinessresearchcompany.com/report/architectural-lighting-global-market-report Interior Lighting Global Market Report 2025 https://www.thebusinessresearchcompany.com/report/interior-lighting-global-market-report Specialty Lighting Global Market Report 2025 https://www.thebusinessresearchcompany.com/report/specialty-lighting-global-market-report Speak With Our Expert: Saumya Sahay Americas +1 310-496-7795 Asia +44 7882 955267 & +91 8897263534 Europe +44 7882 955267 Email: saumyas@tbrc.info The Business Research Company - www.thebusinessresearchcompany.com Follow Us On: • LinkedIn: https://in.linkedin.com/company/the-business-research-company Oliver Guirdham The Business Research Company info@tbrc.info Visit us on social media: LinkedIn Facebook X Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Bayer Frequently Asked Questions (FAQ)

  • When was Bayer founded?

    Bayer was founded in 1863.

  • Where is Bayer's headquarters?

    Bayer's headquarters is located at Kaiser-Wilhelm-Allee 1, Leverkusen.

  • What is Bayer's latest funding round?

    Bayer's latest funding round is PIPE - II.

  • Who are the investors of Bayer?

    Investors of Bayer include Elliott Management and Temasek.

  • Who are Bayer's competitors?

    Competitors of Bayer include Walgreens Boots Alliance, OCON Therapeutics, MorphoSys, Full-Life, Kenvue and 7 more.

Loading...

Compare Bayer to Competitors

Cerba HealthCare Logo
Cerba HealthCare

Cerba HealthCare provides medical diagnostics within the healthcare sector. It offers diagnostic services including proximity biology, specialty biology, clinical trial biology, anatomical and cytological pathology, medical imaging, and preventive biology. These services are used for the diagnosis and management of diseases. It was founded in 1967 and is based in Issy-les-Moulineaux, France.

E
Elfa Medicamentos

Elfa Medicamentos specializes in the retail and distribution of pharmaceutical products. Elfa offers health-related products, including over-the-counter medications, prescription drugs, health supplements, and other medical supplies. The company is known for its commitment to quality, customer service, and accessibility, aiming to improve public health by providing essential pharmaceutical products to individuals and healthcare professionals across the country. It was founded in 2011 and is based in Para, Brazil.

D
Delova Biotech

Delova Biotech is a biotechnology company focused on developing analgesics for chronic pain management. The company specializes in creating pain relief medications for various pain conditions, particularly targeting chronic and acute pain. Delova Biotech's approach includes the use of technologies such as SimSol(TM) for enhancing the solubility of difficult-to-dissolve drugs, and its series of analgesic drugs are designed to provide efficacy and safety compared to traditional analgesics. It was founded in 2017 and is based in Nanjing, Jiangsu.

Chongqing Pharmaceutical (Group) Logo
Chongqing Pharmaceutical (Group)

Chongqing Pharmaceutical (Group) operates in China's pharmaceutical industry. The company specializes in the wholesale and retail of pharmaceutical products, playing a crucial role in the distribution and accessibility of medications across various healthcare settings. It was formerly known as Southwest Branch of China Pharmaceutical Corporation. It was founded in 1950 and is based in Yuzhong, China.

E
Eastman Chemical Company - Tire Additives Business

Eastman is a global specialty chemical company that produces a broad range of advanced materials, additives and functional products, specialty chemicals, and fibers that are found in products people use every day. As a world leader in the diverse markets it serves, Eastman is focused on delivering innovative and technology-based solutions while maintaining its commitment to safety and sustainability.

P
Pfizer

Pfizer is a biopharmaceutical company involved in the discovery, development, and manufacturing of medications and vaccines aimed at improving health outcomes. The company serves the healthcare sector with its medical solutions. It is based in Jakarta, Indonesia.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.